Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $7.3150 (4.43%) ($7.3150 - $7.3150) on Tue. Oct. 10, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.29% (three month average) | RSI | 43 | Latest Price | $7.3150(4.43%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | EDIT declines -2.9% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) ARKG(77%) XBI(77%) IBB(66%) ARKK(62%) IBUY(62%) | Factors Impacting EDIT price | EDIT will decline at least -1.645% in a week (0% probabilities). TBT(-24%) VXX(-16%) UUP(-16%) EDOC(-16%) VIXM(-13%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.645% (StdDev 3.29%) | Hourly BBV | 1.3 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-7.95(-208.68%) | Resistance Level | $7.53 | 5 Day Moving Average | $7.14(2.45%) | 10 Day Moving Average | $7.19(1.74%) | 20 Day Moving Average | $7.53(-2.86%) | To recent high | -21.2% | To recent low | 5.7% | Market Cap | $454m | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |